Preveceutical Med Inc New
(PRVCF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,697 | -9,096 | N/A | N/A | N/A |
| Depreciation Amortization | 132 | 28 | N/A | N/A | N/A |
| Accounts receivable | -15 | 0 | N/A | N/A | N/A |
| Other Working Capital | 1,060 | -1,435 | N/A | N/A | N/A |
| Other Operating Activity | 772 | 4,708 | 0 | 0 | 0 |
| Operating Cash Flow | $-749 | $-5,796 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -6 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1 | -2 | N/A | N/A | N/A |
| Other Investing Activity | -1 | -2 | 0 | 0 | 0 |
| Investing Cash Flow | $-1 | $-8 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 278 | N/A | N/A | N/A | N/A |
| Debt Issued | 328 | 1,278 | N/A | N/A | N/A |
| Debt Repayment | N/A | -524 | N/A | N/A | N/A |
| Common Stock Issued | 211 | 5,020 | N/A | N/A | N/A |
| Other Financing Activity | -163 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $653 | $5,775 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 70 | -1 | N/A | N/A | N/A |
| Beginning Cash Position | 49 | 80 | N/A | N/A | N/A |
| End Cash Position | 22 | 49 | N/A | N/A | N/A |
| Net Cash Flow | $-27 | $-31 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -749 | -5,796 | N/A | N/A | N/A |
| Capital Expenditure | N/A | -6 | N/A | N/A | N/A |
| Free Cash Flow | -749 | -5,802 | 0 | 0 | 0 |